vTv Therapeutics (VTVT) Tops Q1 EPS by 165c
Tweet
Share
E-mailGet Alerts VTVT Hot Sheet
Join SI Premium – FREE
vTv Therapeutics (NASDAQ: VTVT) reported Q1 EPS of $1.65. Revenue for the quarter came in at $36.84 million.
For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Omnicom Media and Netflix partner on AI-powered ad targeting
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
